EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes

Rishi Chanderraj iD, Jennifer M Baker iD, Stephen G Kay, Christopher A Brown iD, Kevin J Hinkle, Daniel J Fergle, Roderick A McDonald, Nicole R Falkowski, Joseph D Metcalf, Keith S Kaye iD, Robert J Woods iD, Hallie C Prescott iD und 2 weitere

European Respiratory Journal · 2023-02 · 61 (2) · 2200910

DOI: 10.1183/13993003.00910-2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 13.10.2022. Verfasst von Rishi Chanderraj und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Hyperoxia, Pneumonia, Ventilator-Associated. Die Arbeit wurde bisher 158-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NLM NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Critically ill patients routinely receive antibiotics with activity against anaerobic gut bacteria. However, in other disease states and animal models, gut anaerobes are protective against pneumonia, organ failure and mortality. We therefore designed a translational series of analyses and experiments to determine the effects of anti-anaerobic antibiotics on the risk of adverse clinical outcomes among critically ill patients.

Methods

We conducted a retrospective single-centre cohort study of 3032 critically ill patients, comparing patients who did and did not receive early anti-anaerobic antibiotics. We compared intensive care unit outcomes (ventilator-associated pneumonia (VAP)-free survival, infection-free survival and overall survival) in all patients and changes in gut microbiota in a subcohort of 116 patients. In murine models, we studied the effects of anaerobe depletion in infectious ( Klebsiella pneumoniae and Staphylococcus aureus pneumonia) and noninfectious (hyperoxia) injury models.

Results

Early administration of anti-anaerobic antibiotics was associated with decreased VAP-free survival (hazard ratio (HR) 1.24, 95% CI 1.06–1.45), infection-free survival (HR 1.22, 95% CI 1.09–1.38) and overall survival (HR 1.14, 95% CI 1.02–1.28). Patients who received anti-anaerobic antibiotics had decreased initial gut bacterial density (p=0.00038), increased microbiome expansion during hospitalisation (p=0.011) and domination by Enterobacteriaceae spp. (p=0.045). Enterobacteriaceae were also enriched among respiratory pathogens in anti-anaerobic-treated patients (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperoxiaPneumonia, Ventilator-AssociatedAnimalsMiceAnti-Bacterial AgentsCohort StudiesRetrospective StudiesCritical IllnessIntensive Care Units

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Medicine Service, Infectious Diseases Section, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Institute for Research on Innovation and Science, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
  • Division of Infectious Diseases, Department of Medicine, Rutgers-New Jersey Medical School, Newark, NJ, USA.

ORCID-Profile: Rishi Chanderraj, Jennifer M Baker, Christopher A Brown, Keith S Kaye, Robert J Woods, Hallie C Prescott, Michael W Sjoding, Robert P Dickson

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NLM NIH HHS
  • National Heart, Lung, and Blood Institute
  • U.S. National Library of Medicine
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Chanderraj, R., Baker, J. M., Kay, S. G., Brown, C. A., Hinkle, K. J., Fergle, D. J., McDonald, R. A., Falkowski, N. R., Metcalf, J. D., Kaye, K. S., Woods, R. J., Prescott, H. C., Sjoding, M. W., & Dickson, R. P. (2023). In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. European Respiratory Journal, 61(2), 2200910. https://doi.org/10.1183/13993003.00910-2022

Vancouver

Chanderraj R, Baker JM, Kay SG, Brown CA, Hinkle KJ, Fergle DJ, et al. In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. European Respiratory Journal. 2023;61(2):2200910. doi:10.1183/13993003.00910-2022

BibTeX
@article{Chanderraj2023,
  author = {Chanderraj, Rishi and Baker, Jennifer M and Kay, Stephen G and Brown, Christopher A and Hinkle, Kevin J and Fergle, Daniel J and McDonald, Roderick A and Falkowski, Nicole R and Metcalf, Joseph D and Kaye, Keith S and Woods, Robert J and Prescott, Hallie C and Sjoding, Michael W and Dickson, Robert P},
  title = {In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes},
  journal = {European Respiratory Journal},
  year = {2023},
  volume = {61},
  number = {2},
  pages = {2200910},
  doi = {10.1183/13993003.00910-2022}
}
Kostenlos starten →